3710 results for «2021»
3710 results
Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure
03 Feb 2022
How to choose a snare and how to create a snare in complex PCI scenarios
19 Dec 2023
Complex percutaneous coronary intervention (PCI) procedures are dramatically increasing in daily practice. Calcified coronary artery lesions and hostile cardiac anatomy may increase the risk of device dislodgment and/or malposition. In such situations, the use of a snare catheter is pivotal to retrieve and/or reposition the device.
Author
Author
Author
Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Femoral artery pseudoaneurysm expansion managed through subcutaneous fat embolization
06 Apr 2021
Femoral artery pseudoaneurysm is a known complication following cardiac catheterization. Rarely, expansion of the pseudoaneurysm can occur and is often catastrophic. We describe a unique method employed by our centre to deal with such a complication.
Author
Giant right coronary artery aneurysm unmasked in the setting of STEMI: killing two birds with one stone
09 Apr 2021
Consult this Twitter case from Ricardo Sanz: an 80-year-old man presenting with inferior STEMI, primary PCI being complicated by the presence of a giant coronary aneurysm in the RCA that hindered the advancement of wires and material towards a small and hidden entry point. Creative off-label...
Author
iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation
04 Nov 2021
Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...
Author
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure
04 Nov 2021
The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.
Author
GUIDE-HF: can continuous pulmonary artery pressure monitoring improve heart failure management?
09 Nov 2021
The main goal of the randomized GUIDE-HF trial was to assess the ability of continuous PAP monitoring to improve outcomes in patients with heart failure NYHA class II-IV and a HF hospitalization within previous 12 months or elevated BNP/NT-proBNP.
Author
Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out
14 Nov 2023
Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.
Author
PCR Seminars 2019
First Patient Enrolled in SELUTION SLR IDE BTK Study
08 Jun 2022
Catalysing a more equitable workforce in medicine – Women as One - EuroPCR 2022
19 May 2022
Founded in 2019 by Marie-Claude Morice and Roxana Mehran, the mission of Women as One is to promote talent in medicine by providing unique professional opportunities to women physicians.
Author
Author
We CARE about hearts - EuroPCR 2022
19 May 2022
The aims of We CARE are to rebuild patient confidence and help stakeholders provide effective and timely cardiac care through knowledge, education and training.
Author
MedAlliance’s SELUTION SLR™ drug-eluting balloon (DEB) receives FDA Investigational Device Exemption (IDE) approval, making it the first limus DEB to be available to US patients
26 May 2022
MedAlliance SELUTION SLR Receives Second FDA IDE Approval
09 Aug 2022
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
First US Patient Enrolled in SELUTION SLR IDE Peripheral Study
22 Aug 2022
Repair of iatrogenic perforation of a pulmonary artery side branch with Micro Vascular Plug System
04 Dec 2022
Pulmonary artery rupture during right catheterization is a serious complication that needs to be solved urgently. The patient can be stabilized by tamponade of the pulmonary artery with the catheter balloon tip, as demonstrated in this image in cardiology.
Singapore approves novel Hydra TAVI system
28 Oct 2024